Gastroesophageal Reflux Disease

References

1. ↵
   1. El-Serag HB,
   2. Sweet S,
   3. Winchester CC,
   4. Dent J

   Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871-880.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Katz PO,
   2. Gerson LB,
   3. Vela MF

   Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308-328.

   OpenUrlCrossRefPubMed
3. ↵
   1. Forgacs I,
   2. Loganayagam A

   Overprescribing proton pump inhibitors. BMJ. 2008;336(7634):2-3.

   OpenUrlFREE Full Text
4. ↵
   1. Agency for Healthcare Research and Quality (AHRQ), National Guideline Clearinghouse

   Diagnosis and treatment of gastroesophageal reflux disease (GERD). AHRQ website. https://www.guideline.gov/syntheses/synthesis.aspx?id=50025. Published May 2008. Revised June 2014. Accessed January 20, 2016.
5. ↵
   1. Anderson WD 3rd.,
   2. Strayer SM,
   3. Mull SR

   Common questions about the management of gastroesophageal reflux disease. Am Fam Physician. 2015;91(10):692-697.

   OpenUrlPubMed
6. ↵
   1. Gupta SK,
   2. Hassall E,
   3. Chiu YL,
   4. Amer F,
   5. Heyman MB

   Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. Dig Dis Sci. 2006;51(5):858-863.

   OpenUrlCrossRefPubMed
7. ↵
   1. Lightdale JR,
   2. Gremse DA, Section on Gastroenterology, Hepatology, and Nutrition

   Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics. 2013;131(5):e1684-e1695.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Rosen R

   Gastroesophageal reflux in infants: more than just a pHenomenon. JAMA Pediatr. 2014;168(1):83-89.

   OpenUrlCrossRefPubMed
9. ↵
   Drugs for peptic ulcer disease and GERD. Treat Guidel Med Lett. 2014;12(140):25-30.

   OpenUrlPubMed
10. ↵
    1. Oelschlager BK,
    2. Quiroga E,
    3. Parra JD,
    4. Cahill M,
    5. Polissar N,
    6. Pellegrini CA

    Long-term outcomes after laparoscopic antireflux surgery. Am J Gastroenterol. 2008;103(2):280-287.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Choosing Wisely

    American Academy of Pediatrics. Choosing Wisely website. http://www.choosingwisely.org/clinician-lists/american-academy-pediatrics-acid-blockers-motility-agents-for-gastroesophageal-reflux-in-infants/. Released March 17, 2014. Accessed February 26, 2016.
12. ↵
    1. Shaheen N,
    2. Ransohoff DF

    Gastroesophageal reflux, Barrett Esophagus, and esophageal cancer: scientific review. JAMA. 2002;287(15):1972-1981.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Shaheen N,
    2. Falk GW,
    3. Iyer PG,
    4. Gerson LB

    ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol. 2016;111(1):30-50.

    OpenUrlCrossRefPubMed
14. ↵
    1. Shaheen NJ,
    2. Weinberg DS,
    3. Denberg TD,
    4. Chou R,
    5. Qaseem A,
    6. Shekelle P, Clinical Guidelines Committee of the American College of Physicians

    Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med. 2012;157(11):808-816.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Zimmerman TG

    Common questions about Barrett esophagus. Am Fam Physician. 2014;89(2):92-98.

    OpenUrlPubMed
16. ↵
    1. Antoniou T,
    2. Macdonald EM,
    3. Hollands S, et al.

    Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. CMAJ Open. 2015;3(2):E166-E171.

    OpenUrlCrossRefPubMed
17. ↵
    1. Lazarus B,
    2. Chen Y,
    3. Wilson FP, et al.

    Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238-246.

    OpenUrlPubMed
18. ↵
    1. Schoenfeld AJ,
    2. Grady D

    Adverse effects associated with proton pump inhibitors. JAMA Intern Med. 2016;176(2):172-174.

    OpenUrlCrossRefPubMed
19. ↵
    1. Gomm W,
    2. von Holt K,
    3. Thomé F, et al.

    Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis [published online ahead of print February 15, 2016]. JAMA Neurol. doi:10.1001/jamaneurol.2015.4791.